Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Reagan

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Cancer|July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesThomas A Ollila, Rebecca H Masel, John L Reagan, et al.
British Journal of Haematology|March 13, 2019
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapyAdam J Olszewski, Anna D Chorzalska, Annette S Kim, et al.
Molecular Oncology|February 28, 2018
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemiaAnna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, et al.
British Journal of Haematology|March 13, 2018
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphomaJorge J Castillo, Thomas Guerrero-Garcia, Francesco Baldini, et al.
Blood Advances|September 22, 2021
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphomaAdam J Olszewski, Anna D Chorzalska, Max Petersen, et al.
Blood|July 29, 2025
HiJAKing the Hematopoietic System: A Low-Frequency JAK2V617F Clone Drives Myeloproliferative Neoplasm PathologyDennis M Bonal, Alissa Oakes, Anna Chorzalska, et al.
JAMA Oncology|January 9, 2025
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical TrialGregory A Abel, Haesook T Kim, Ira Zackon, et al.
Blood|September 15, 2018
Bone marrow-specific loss of Anna Chorzalska, John Morgan, Nagib Ahsan, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Cancer|July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesThomas A Ollila, Rebecca H Masel, John L Reagan, et al.
British Journal of Haematology|March 13, 2019
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapyAdam J Olszewski, Anna D Chorzalska, Annette S Kim, et al.
Molecular Oncology|February 28, 2018
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemiaAnna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, et al.
British Journal of Haematology|March 13, 2018
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphomaJorge J Castillo, Thomas Guerrero-Garcia, Francesco Baldini, et al.
Blood Advances|September 22, 2021
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphomaAdam J Olszewski, Anna D Chorzalska, Max Petersen, et al.
Blood|July 29, 2025
HiJAKing the Hematopoietic System: A Low-Frequency JAK2V617F Clone Drives Myeloproliferative Neoplasm PathologyDennis M Bonal, Alissa Oakes, Anna Chorzalska, et al.
JAMA Oncology|January 9, 2025
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical TrialGregory A Abel, Haesook T Kim, Ira Zackon, et al.
Blood|September 15, 2018
Bone marrow-specific loss of Anna Chorzalska, John Morgan, Nagib Ahsan, et al.
Pageof 8